Johnson & Johnson (J&J) has secured support for its proposed $6.5-billion settlement aimed at resolving tens of thousands of lawsuits that allege its baby powder and other talc products caused cancer.
According to a Bloomberg report, more than 75% of claimants have voted in favor of the settlement, reaching the threshold J&J set for its third attempt to place its subsidiary into bankruptcy protection to address the litigation.
